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Introduction
Human epidermal keratinocytes have long been recognised as potentially attractive recipient cells for gene therapy. [1] [2] [3] The epidermis is a self-renewing tissue in which terminally differentiating cells are continuously replaced through proliferation of a population of stem cells. Keratinocytes from adults can be grown in culture, remaining diploid, and within 1 month can generate a sufficient surface area to cover the entire body. Autografts of cultured keratinocytes are a well-established treatment for burns victims and long-term follow-up shows good tissue architecture and persistence of the graft for years. In addition, because the keratinocytes are grafted on to the surface of the body it is easy to monitor graft 'take' by visual inspection.
Keratinocytes are difficult to stably transfect with plasmid constructs, 4 but close to 100% infection can be achieved with retroviral vectors and during repeated passaging there is stable expression of the transduced gene. [5] [6] [7] [8] In addition, expression levels of transduced genes can be within the physiological range, as demonstrated for both secreted 9 and cell-associated 10 proteins. The outcome of attempts to achieve long-term expression of transduced genes when keratinocytes are grafted on to immunocompromised mice has been disappointing. In the first demonstration that a therapeutic protein, factor IX, could reach the bloodstream from transduced primary keratinocytes, 9 the level of production decreased substantially within 7 days. Longer term expression of factor IX, for 4-6 weeks, has since been achieved, 11, 12 but in each case there was a progressive decline in production with time. Keratinocytes expressing other secreted or cytoplasmic proteins have also been examined and there was always loss of expression within 2 months of grafting. 7, 10, 13 Three potential reasons for the failure of long-term gene expression have been put forward. In some cases the problem has been due, at least in part, to failure of the graft, with pure keratinocyte sheets or suspensions no longer maintaining a healthy stratified epithelium after 7-14 days. 7, 9, 12 In other cases there is good evidence that although integrated retroviral vector sequences persist, LTR-driven gene expression ceases; 13 there have been attempts to overcome this problem by introducing keratinocyte-specific enhancers, but it is too soon to say how much of a difference these can make. 12 Finally, there has been some debate as to whether or not the transduced cell population includes the stem cells, since failure to target stem cells will result in loss of transduced cells through terminal differentiation. 5, 7, 14 Our hypothesis was that if keratinocyte infection and grafting conditions could first be optimised it would then be possible to concentrate on improved vector design. For the experiments to be reported the chick ␤ 1 integrin subunit was chosen as the transduced gene because expression and function could be monitored on a cell-bycell basis and because of the role of ␤ 1 integrins in regulating keratinocyte terminal differentiation. 15, 16 Retrovirally transduced human keratinocytes L Levy et al 914
Results

Retroviral vector
The retroviral vector used is shown in Figure 1a . In common with other laboratories, 7,17 we found that neomycin resistance was unsuitable as a selectable marker for stably transduced human keratinocytes, since uninfected cells took several days to die in the drug and the growth potential of infected cells was reduced relative to untreated controls. Instead, we used puromycin resistance as the selectable marker, because it rapidly kills nontransduced keratinocytes and has no clear deleterious effects on transduced cells. 6, 8 In the construct shown in Figure 1a the integrin gene was placed under the control of the retroviral LTR because in earlier constructs we achieved high-level gene expression via the LTR. 6, 8 Using antibodies specific for the chick ␤ 1 integrin subunit that do not cross-react with the endogenous human subunit it is possible to monitor the efficiency of retroviral infection on a cell-by-cell basis. ␤ 1 integrins are extracellular matrix receptors that consist of heterodimers of ␤ 1 and ␣ subunits; the chick ␤ 1 subunit has previously been shown to heterodimerise with mammalian ␣ subunits in transfected cells. 18 For our studies we expressed both the wild-type chick ␤ 1 integrin subunit and a series of point and deletion mutations within the cytoplasmic domain that prevent targeting to focal adhesions. 18 Ecotropic packaging line As shown schematically in Figure 1b the first step in retroviral infection was to transfect the retroviral vector into the ecotropic packaging line, GP+E. 19 We compared two different methods: calcium phosphate-mediated transfection and the Superfect transfection reagent kit (Qiagen, Crawley, UK) which is based on polycationic microspheres. Using flow cytometry and Western blotting we compared the expression of the chick ␤ 1 integrin subunit in polyclonal, puromycin-resistant GP+E populations. The best (Figure 2b ) and worst (Figure 2a ) surface expression levels achieved are illustrated. In Figure 2a there are fewer than 2% of cells with fluorescence above background whereas in Figure 2b Ͼ50% of the cells are positively labelled. By Western blotting, the chick ␤ 1 subunit could be detected in both populations of GP+E, but those cells with the best flow cytometry profiles expressed much higher total levels of chick ␤ 1 , both the mature subunit and immature, nonglycosylated pre-␤ 1 20 ( Figure 2c , track 2) than those cells with the worst profiles ( Figure 2c , track 1). GP+E cells with the profile shown in Figure 2a were not efficient at infecting the amphotropic packaging line and only cells with the profile shown in Figure 2b were used. Good transfection of GP+E was achieved more frequently with Superfect transfection than with calcium phosphate-mediated transfection in these experiments.
Amphotropic packaging line
Producer lines that are generated by retroviral infection have higher viral titres than those generated by transfection and for this reason virus released into the culture medium by confluent GP+E cells was used to infect the amphotropic packing line AM12, 21 as illustrated schematically in Figure 1b 22 We achieved the most efficient infection of AM12 by collecting medium that had been conditioned for 48-72 h. The infection protocol involved mixing the virus-containing medium with polybrene before addition to the AM12 cells. 22 Puromycin was added to the medium 2 days following infection and a polyclonal AM12 population selected.
Surface expression of the chick ␤ 1 integrin subunit was always low in the polyclonal AM12 population ( Figure   Figure 2 3a) and the viral titre was only 10 3 -10 4 c.f.u./ml. It was therefore necessary to clone the AM12 cells. Direct cloning of the polyclonal population led to a relatively low frequency of highly expressing clones (none of 40 for the construct illustrated). The frequency was improved when the polyclonal population was subjected to FACS selection before cloning. As shown in Figure 3b , when the 5-10% of cells in the polyclonal population with the highest surface levels of the chick ␤ 1 integrin subunit were isolated and grown to confluence there was a marked improvement in expression with Ͼ50% of cells positively stained. When these cells were cloned the frequency of highly positive clones, such as the one illustrated in Figure 3c , was greatly increased (eight of 10 for the construct illustrated). Western blotting confirmed that the clones with highest surface expression of the chick integrin had the highest total levels (Figure 3d and data not shown).
In every clone examined, high surface or total chick ␤ 1 integrin levels correlated with high retroviral titre. The titre of the clone expressing the wild-type chick subunit that was subsequently used to infect keratinocytes was 5 × 10 5 c.f.u./ml and the titre of an adhesion-defective mutant in which the NPIY motif at amino acids 785-788 was changed to YPRF was 8 × 10 5 c.f.u./ml. Analysis of AM12 DNA by Southern blotting showed that in a high proportion of those puromycin-resistant clones that failed to express chick ␤ 1 protein the chick ␤ 1 gene had undergone mutation (data not shown).
Infection of primary human keratinocytes
Stocks of human epidermal keratinocytes from neonatal foreskin were cultured in the presence of a 3T3 feeder layer. 23, 24 We achieved maximal infection with the retroviral vectors by plating the keratinocytes at clonal seeding density or greater on to mitotically inactivated packaging cells, using the packaging cells as a substitute for the 3T3 cells, as shown schematically in Figure 4 . Puromycin was added after 2 days and after a further 1-2 days the AM12 cells were selectively removed by EDTA treatment and replaced with puromycin-resistant 3T3 cells.
Keratinocytes expressing the wild-type chick ␤ 1 subunit grew more slowly than the empty vector controls, but none of the adhesion-defective mutants, such as the YPRF mutant, had any effect on keratinocyte proliferation (data not shown). A likely explanation for the effect of the wild-type integrin subunit is that increased surface integrin expression resulted in some inhibition of the lateral cell migration that normally occurs as the clones expand. 25, 26 The expression of the chick ␤ 1 integrin subunit was examined by flow cytometry and immunoprecipitation (Figure 5a and b). The levels of surface expression achieved were comparable with that of the endogenous human subunit (Figure 5a and data not shown). 20 Immunoprecipitation of metabolically labelled keratinocytes revealed that the chick subunit underwent maturation (glycosylation) and formed heterodimers with the endogenous ␣ subunits (Figure 5b ). The ratio of unglycosylated to glycosylated forms of the chick ␤ 1 subunit, whether mutant or wild type, was greater than that of the endogenous, human, ␤ 1 subunit ( Figure 5 , compare lanes 1 and 2), suggesting either that the availability of ␣ subunits was the limiting factor in cell surface expression or that the chick subunit was not processed as efficiently as the endogenous ␤ 1 subunit. The cellular distribution of the chick ␤ 1 subunit was examined by confocal microscopy (Figure 5c and d) . All constructs tested showed high levels of expression on lateral and apical membranes (Figure 5c ). In addition, the wild-type chick ␤ 1 subunit clustered in focal adhesions (Figure 5d ) whereas mutants previously reported to be defective in focal adhesion targeting did not (data not shown). 18 Grafting of transduced keratinocytes into immunodeficient mice Having achieved efficient and stable expression of the chick ␤ 1 subunit in human keratinocytes we examined whether sustained expression could be achieved when keratinocytes were grafted in vivo. We compared grafts of pure keratinoctye sheets and grafts of keratinocytes grown on a dermal substrate; we also compared grafts in nude or SCID mice. The YPRF mutant chick ␤ 1 subunit was chosen as the transduced gene because, unlike the wild-type subunit, it did not affect keratinocyte proliferation in culture.
Pure keratinocyte sheets were obtained by allowing transduced or uninfected keratinocytes to reach confluence and then harvesting them as an intact sheet using the enzyme Dispase. 27 One week after grafting subcutaneously into nude or SCID mice the histological appearance of the graft resembled normal human epidermis (data not shown) 27 ,28 but a week later the graft had degenerated (data not shown). 7 In order to prolong the life of the graft we examined the effect of culturing keratinocytes on a dermal substrate known as a DED (for 'de-epidermised dermis'). 29 The substrate was prepared by removing the epidermis from adult human skin, leaving the basement membrane intact. Cells within the dermis were killed by repeated cycles of freezing and thawing.
Transduced or uninfected keratinocytes were seeded on to the dermal substrate and exposed at the airmedium interface, conditions that have previously been reported to improve the histological appearance of the cultured epidermis. 29, 30 Twelve days after seeding on to the substrate, when a multilayered epidermal sheet had formed, the cells were grafted subcutaneously into nude or SCID mice. We found that grafts in which the dermal substrate was placed in contact with the muscle fascia had the advantage over grafts placed in the opposite orientation that they did not adhere to the surrounding mouse tissue and therefore could be easily excised for analysis.
Grafts of transduced or uninfected keratinocytes were excised at intervals for up to 4 months after grafting. During the first week the epidermal sheet had few viable layers and an excess of cornified layers, but by 1 month the histology more closely resembled normal epidermis (Figure 6a and data not shown) . The improved appearance of the grafted epidermis correlated with the migration of host cells into the dermal substrate. By 1 month the dermal substrate was becoming vascularised and was populated by cells of fibroblastic morphology. There was no difference between the histological appearance of grafts in nude or SCID mice during the first 4 weeks and for later time-points only SCID mice were used. Further cellularisation of the DED and improvement of epidermal morphology occurred by 9 weeks (Figure 6b ) and was maintained at 16 weeks (Figure 6c) .
Grafts of transduced keratinocytes were harvested at intervals and immunofluorescence staining of histological sections was used to examine expression of the chick ␤ 1 subunit, endogenous integrins and a range of markers of keratinoctye differentiation. The chick integrin subunit was detected in all cells in the basal and spinous layers at every time-point examined, up to and including 16 weeks after grafting (Figure 7a and data not shown). In contrast, the endogenous ␤ 1 integrins examined, ␣ 2 ␤ 1 and ␣ 3 ␤ 1 (Figure 7b and data not shown), and ␣ 6 ␤ 4 ( Figure 7c ) were confined to the basal layer by 9 weeks. ␣ 6 ␤ 4 Staining was concentrated at the basement membrane zone (Figure 7c ) consistent with its normal localisation within human skin. Few cells in the graft expressed keratin 16 ( Figure  7d ) but suprabasal keratinocytes were positive for keratin 10 ( Figure 7e ). Involucrin was expressed by cells in the upper spinous and granular layers (Figure 7f) . The antibodies to involucrin and ␤ 1 integrins were specific for the human proteins, confirming the origin of the keratinocytes in the grafts.
Discussion
The sustained expression of the chick ␤ 1 gene 4 months after grafting is one of the best results reported so far in keratinocyte gene therapy models, both in terms of the proportion of transduced cells and the sustained level of expression. We believe that our success is not due to any major advance in terms of methodology or reagents, but is due rather to the optimisation of individual steps, ranging from transfection of the ecotropic packaging line through selection of cloned packaging cells, infection of keratinocytes and grafting. The retroviral vector and packaging lines are those that we have used previously to achieve high-level expression of transduced genes that is stable over several passages of human keratinocytes in vitro. 6, 8 The choice of the chick ␤ 1 integrin subunit as the transduced gene had the advantage that we could monitor expression on a cell-by-cell basis during generation of the packaging lines. From such analysis it was clear that unless good expression was achieved in the polyclonal ecotropic packaging line attempts to obtain good amphotropic lines always failed. Equally, we had little success in infecting keratinocytes with polyclonal amphotropic cells although this may depend on the nature of the transduced gene. 8 The most efficient method of obtaining good AM12 clones was to FACS sort the starting population before cloning. In the case of the chick integrin subunit and other genes we have studied 6 the AM12 clones with the highest level of expression of the transduced gene also had the highest viral titre. Titres of Ͼ10 5 c.f.u./ml are acceptable for infecting keratinocytes, 5 and we routinely achieve titres in the range of 3 × 10 5 -5 × 10 6 c.f.u./ml with the protocols described. Use of the packaging line as a feeder layer 6-9,12 allows sustained exposure of keratinocytes to retrovirus over a period of days, thereby maximising infection since not all keratinocytes are actively proliferating at any given time.
Pure keratinocyte sheets grafted subcutaneously in immunocompromised mice 27 have an excellent histological appearance but did not survive beyond 2 weeks, whether grafted into nude or SCID mice.
7 Clinical experience of treating burns victims with autografts of keratinocyte sheets has been that the presence of a dermal substrate improves 'take' and gives a good cosmetic result. 31 Our experience was that the presence of a deepidermised human dermal substrate resulted in excellent keratinocyte histology and the dermal substrate was rapidly colonised with fibroblasts and vascularised, con- sistent with earlier reports.
13,32 By 9 weeks the grafted epidermis had a normal rather than a hyperproliferative phenotype, as judged by a number of criteria: there was strong keratin 10 expression, little expression of keratin 16, onset of involucrin expression in the mid-spinous layers, and endogenous integrin expression was confined to the basal layer. 30, 33, 34 Although we placed the grafts subcutaneously for convenience the same type of graft has been successfully placed at the skin surface 13, 32 as would obviously be the case in clinical applications.
The chick ␤ 1 integrin subunit was detected in both basal and spinous layers of the grafts, consistent with the sustained expression of the vector in terminally differentiating keratinocytes reported previously. 6, 8 The staining pattern in Figure 7a is highly suggestive of surface expression in the spinous layers, which is surprising because none of the endogenous ␣ subunits examined were expressed above the basal layer and heterodimerisation is thought to be necessary for surface expression of the ␤ 1 subunit. 20 Suprabasal integrin expression is correlated with hyperproliferation in human epidermis 30, 33 and although, as discussed above, the graft did not appear hyperproliferative, it would be interesting to investigate whether expression of the chick ␤ 1 integrin subunit has any effect on proliferation within the graft.
The sustained expression of the chick ␤ 1 integrin subunit 4 months after grafting is a considerable improvement over previous attempts to achieve long-term retroviral vector expression in vivo. Since the average transit time from the basal to the cornified layers is about 1 month in normal human epidermis we are reasonably confident that the stem cells were targeted in the original infection. Although the YPRF mutant used in the grafts did not affect keratinocyte proliferation in culture or mediate ECM adhesion 18 (data not shown) we have evidence that it can suppress suspension-induced terminal differentiation 15, 16 (data not shown) and thus we cannot rule out the possibility that expression of the YPRF mutant confers a selective advantage on the transduced cells. It will now be interesting to test other transduced genes in the experimental model.
In conclusion, the major obstacles to the use of keratinocytes as recipient cells for retroviral gene therapy appear to have been overcome without the need to develop new vectors. Just as some transduced genes may confer a selective advantage on keratinocytes others will undoubtedly be growth inhibitory and the next challenge is to apply inducible retroviral vectors 8 in this system as these have many potential clinical applications.
Materials and methods
Construction of retroviral vectors ␤pRSVneo plasmids containing the wild-type chick ␤ 1 integrin cDNA or a series of point and deletion mutants of the cytoplasmic domain were generously provided by A Reszka and AF Horwitz, University of Illinois. 18 The chick cDNAs were removed from the ␤pRSVneo vector either as SalI or SalI-EcoRI fragments and cloned into SalI-EcoRI sites in the retroviral vector pBabe puro. 35 For the genetic manipulation of plasmids containing Retrovirally transduced human keratinocytes L Levy et al 920 proviral structures it is essential to use bacterial hosts that are rec A − so as to avoid high recombination frequencies resulting from the presence of two LTRs, and the host we selected was DH5␣. 22 We used a ratio of foreign DNA: vector of у5 in order to yield the maximum amount of useful ligation products.
Producer cell lines
Stocks of packaging cells were cultured in DMEM and 10% FCS. Retroviral DNA was transfected into the ecotropic packaging cell line GP+E (GP+E-86 19 ) either via calcium phosphate-mediated transfection or using the Superfect transfection reagent kit (Qiagen). The packaging cells were split at the density of Ͻ10 5 per 100-mm dish 24 h before transfection. Five to 20 g of retroviral DNA was applied to the cells for 3 h.
Virus was obtained from stable GP+E producer cell lines by allowing the cells to reach confluence, removing the spent medium, replacing it with 1/2 volume of fresh medium and harvesting the conditioned medium 48-72 h later. 22 Retroviral infection of the amphotropic packaging cell line AM12 (GP+envAm12) 21 was performed after filtering producer cell culture supernatants through a 0.45-m filter and adding polybrene to a final concentration of 8 g/ml.
22 Supernatants were added neat to a 100-mm dish that had been seeded with 2 × 10 5 cells 24 h before infection. Infection was allowed to proceed for 2 h and then the viral supernatant was removed and replaced with fresh medium. Forty-eight hours later the selective medium (containing 2.5 g/ml puromycin) was added and changed every third day until a polyclonal drugresistant population was obtained. For cloning, cells were seeded at 100-10 3 per 100-mm dish and 20-40 drugresistant colonies were picked when they had reached a size that was visible without the aid of a microscope. Viral titre was determined by infection of HeLa cells. HeLa cells were plated at a density of 4 × 10 5 per 100-mm dish. Medium conditioned for 2 days by a confluent 100-mm dish of AM12 producer cells was collected, filtersterilised, mixed with 8 g/ml polybrene, subjected to serial dilution in fresh medium and added to the HeLa cells for 4 h. The next day the HeLa cells were replated at a range of dilutions and the number of puromycinresistant clones determined 10 days later. When clones of AM12 producer cells were tested for helper-virus contamination using 3T3 cells as indicators they were found to be helper-free. 22 Keratinocyte culture and infection with retroviral vectors Normal human epidermal keratinocytes from neonatal foreskins (strains km, kq, z, passages 2-3) were cultured on a feeder layer of J2-3T3 mouse embryo fibroblasts pretreated with 4 g/ml mitomycin C (Sigma, Poole, UK) as described previously. 23, 24 The culture medium (FAD+FCS+HICE) consisted of one part Ham's F12 medium and three parts Dulbecco's modification of Eagle's medium, supplemented with 1.8 × 10 −4 m adenine (FAD), 10% foetal calf serum (FCS), 0.5 g/ml hydrocortisone, 5 g/ml insulin, 10 −10 m cholera toxin and 10 ng/ml epidermal growth factor (HICE). Cells were grown at 37°C in a humid atmosphere containing 5% CO 2 . The culture medium was changed every 2-3 days. Keratinocytes were harvested by first removing the feeders with EDTA and then treating the keratinocytes with trypsin/EDTA. Pre-confluent or newly confluent cultures were used for all experiments.
For retroviral infection 10 5 keratinocytes were plated per 100-mm dish on to AM12 producer cells that had been pre-treated with 4 g/ml mitomycin C. After 2 days 1 g/ml puromycin was added to the medium. The producer cells were removed 3-4 days after plating and replaced with puromycin-resistant J2-3T3 cells (prepared by transfection of J2-3T3 with pBabe puro; kindly provided by L Goodman, Imperial Cancer Research Fund, London, UK). Infected keratinocytes were used for experiments several days later or following passage on puromycin-resistant J2-3T3 cells in medium supplemented with 1 g/ml puromycin. Western blotting Confluent AM12 producer cells were rinsed in PBSABC, then extracted in lysis buffer containing 1% NP40 in 50 mm Tris-HCl, pH 7.5, 150 mm NaCl, 5 mm MgCl 2 , 2 mm PMSF and 20 m leupeptin. 20 The cells were scraped from flasks and cell residues were pelleted at 10 600 g for 10 min at 4°C. Protein concentrations were determined with a BioRad Dc protein assay kit (BioRad, Hercules, CA, USA).
Five microgrammes of lysate were loaded per track on to 7.5% SDS-PAGE gels under nonreducing conditions. Transfer to Immobilon PVDF membrane (Millipore, Harlow, UK) was performed at 200 mA for 1 h using a semidry Milliblot graphite electroblotter I system (Millipore). Membranes were blocked with 5% skimmed milk powder (Marvel, Premier Brands UK, Stafford, UK), 1% bovine serum albumin in PBS/0.05% Tween-20 (PBS/Tween) overnight at 4°C and incubated with the W1B10 antichick ␤ 1 integrin antibody 37 (50 g/ml) diluted in 5% skimmed milk in PBS/Tween for 1 h. After four washes in PBS/Tween, the membranes were incubated for 1 h with horseradish peroxidase-conjugated anti-mouse IgG (DAKO, High Wycombe, UK) diluted in PBS/Tween. The membranes were washed in PBS/Tween and immunoreactive proteins were visualised by chemiluminescence (ECL, Amersham International, Amersham, UK). All incubation and washing steps were performed at room temperature.
Immunoprecipitation
For metabolic labelling of integrins, keratinocytes were incubated for 18-20 h in FAD+HICE containing 10% dialysed FCS and 50 Ci/ml 35 S methionine and cysteine (TransS 35 label, Ͼ100 Ci/mmol, ICN Biochemicals, High Wycombe, UK). The cells were rinsed in PBSABC and lysed in the same buffer as used for Westen blotting. The lysates were clarified by centrifugation at 20 800 g for 5 min. Aliquots were equalised on the basis of TCA-precipitable radioactivity.
Lysates were incubated with primary antibodies (P5D2 8 or W1B10) under conditions of antibody excess for 3 h on ice. Rabbit anti-mouse IgG (ICN Biomedicals) was added for the last hour. Fifty microlitres of a 1:1 (v/v) suspension of protein A-Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) was then added and mixed end over end for 45 min at 4°C. Beads and immune complexes were washed as described previously, 20 resuspended in SDS-PAGE sample buffer, boiled for 5 min, and resolved on 7.5% polyacrylamide gels. Gels were stained with Coomassie Blue, destained, treated with 'Amplify' (Amersham, Rochester, NY, USA), dried down and exposed to Kodak XAR5 radiographic film at −70°C. 
Grafting
Keratinocytes were either grafted as pure stratified sheets of cells or after culture on dead, de-epidermised dermis (DED). The sheets were prepared by allowing keratinocytes to reach confluence in 35 mm dishes and then releasing them from the dish with 2.5 mg/ml Dispase II (Boehringer Mannheim, Lewes, UK). 27 The DED cultures were prepared by seeding keratinocytes at a density of 10 5 per 1 cm 2 piece of DED, as described previously. 30 Grafts of DED cultures were performed under sterile conditions using 6-week-old pathogen-free C.B.17 scid/scid or athymic nude mice which were anaesthetised either by an intraperitoneal injection of 0.032 mg/g Hypnomidate (Janssen-Cilag, Issy-les-Moulineaux, France) in the case of SCIDs or by inhalation of Fluothane (Zeneca Pharmaceuticals, Macclesfield, UK) in the case of the nudes. An area of the back was shaved and cleaned with 70% ethanol, then a 1 cm lateral incision was made into the full thickness of the mouse skin. Underlying connective tissue was separated from the skin in a small area anterior to the incision using a blunt seeker and the DED was carefully placed into the sub-dermal space, keeping the keratinocytes uppermost. The incision was closed using 9-mm Clay Adams clips (Becton Dickinson) and the mice were allowed to recover. SCID mice were housed in pathogen-free conditions for the duration of the experiment. Samples for immunohistological examination were taken at intervals for up to 16 weeks after grafting by killing the mice and excising the intact DED. The DED was snap-frozen in liquid nitrogen.
Epithelial sheets of pure keratinocytes were also grafted in SCID mice and athymic nude mice, essentially as described previously. 27 Keratinocyte sheets were transferred to the graft site on a 1 cm 2 piece of sterile Silastic (Dow Corning, Midland, MI, USA) where they were implanted under a flap of skin. The Silastic was placed in contact with the muscle fascia with the basal layer of keratinocytes in contact with the dermis of the mouse. The skin flap was closed with surgical clips. The grafts were harvested at 1, 2 and 4 weeks and examined histologically.
Immunostaining of tissue sections
Each frozen graft was embedded in OCT compound. Cryostat sections (6 m) were cut on to silane-coated slides and air dried for 30 min. The sections were fixed in 4% paraformaldehyde in PBS for 15 min and blocked in 0.2% fish skin gelatin (FSG) in PBS for 30 min at room temperature. Primary monoclonal antibodies were diluted in 0.2% FSG and applied to the sections for 1 h at room temperature. The slides were washed three times in PBS for 15 min then incubated with FITC-conjugated goat anti-mouse IgG diluted in 0.2% FSG for 30 min at room temperature, followed by three washes in PBS for 15 min. The slides were mounted in Gelvatol and examined with a Zeiss Axiophot microscope. The following antibodies were used (specificity indicated in brackets): VM-2 (human ␣ 3 ␤ 1 integrin), P5D2 (human ␤ 1 integrins), G 0 H 3 (human ␣ 6 integrin subunit), HAS4 (human ␣ 2 ␤ 1 ), LL025 (human keratin 16), LHP2 (human keratin 10), SY5 (human involucrin), and W1B10 (chick ␤ 1 integrins). The source of each antibody has been described previously. 8, 30, 37 
